Latest MedImmune Stories
The makers of FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) and the "CSI: Cyber" star launch national campaign to dispel common misconceptions about flu and annual vaccination
New research report “Global Intranasal Drug Delivery Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
Emerging technologies will include 'smaller than a fingernail' nanopatch vaccines LONDON, Sept.
MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas
MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved
LONDON and BOSTON, June 24, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that its President,
MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic BASEL, Switzerland, June 16, 2014
- totally perplexed and mixed up.